Research at CODA
Curious about CODA’s current studies?
Contact us at 503-341-6103 or email email@example.com
CODA Research generally participates in two types of studies: (1) surveys about your opinions, beliefs, or practices and (2) clinical trials.
Participants in any clinical trial are chosen based on eligibility. For example, in a study about medication treatments for opioid dependence, we would recruit participants with a dependence on heroin, prescription pain medications, etc. All of our studies provide you with clear explanations of your rights and risks for participating.
Important things to know about our studies:
All medications used are FDA approved.
Your participation and personal information is confidential.
Compensation is often part of the study agreement.
CODA Research is currently recruiting for two studies:
- Worried about someone who is using cocaine or crack? Worried about YOUR cocaine or crack use? Researchers at CODA are conducting a voluntary research study for adults ages 18 to 65 that is completely confidential. The no-cost treatment may include a placebo. Eligible participants will be compensated. Call CODA Research at 971-235-7686 or email firstname.lastname@example.org.
- Methamphetamine use problems? Researchers at CODA are conducting a voluntary research study for adults ages 18 to 65. The no-cost treatment may include a placebo. Eligible participants will be compensated. Call CODA Research at 503-309-3841 or email email@example.com
More about us:
Our mission is to conduct and support mental health and substance use research to inform evidence-based care and improve patient health and treatment outcomes
CODA’s nationally recognized Research Program, which to date has randomized over 3,000 study participants in 20 funded trials, has collaborated with Oregon Health & Science University (OHSU), Geisel School of Medicine at Dartmouth College, University of Pittsburgh, University of Washington, Virginia Commonwealth University, Kaiser Permanente, and other institutions on research funded by National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism (NIAAA) and other foundations and agencies. CODA is currently the only site nationally to be participating in trials testing medications for both methamphetamine and cocaine use disorders. Earlier clinical trials examined use of extended-release naltrexone and buprenorphine, leading CODA to be early adopters of these FDA-approved medications for opioid use disorders.